EQUITY (Tables)

12 Months Ended

Jun. 30, 2024

Equity [Abstract]

SCHEDULE OF WARRANTS OUTSTANDING

	Warrants Outstanding		Exercise Price		Expiration Date
July 2021 IPO		87,500	$	7.00	June 2026
November 2021 SPA		555,000	$	1.75	November 2026
November 2021 SPA		195,000	$	1.75	May 2027
Total		837,500

SCHEDULE OF STOCK OPTION FAIR VALUE ASSUMPTION

Stock options have been recorded at their fair value. The Black-Scholes option-pricing model assumptions used to value the issuance of stock options under the Plan for the specific periods below are noted in the following table:

	For the Years Ended June 30,
	2024			2023
Weighted average expected terms (in years)		5.1			6.0
Weighted average expected volatility		103.3	%		88.8	%
Weighted average risk-free interest rate		4.3	%		3.9	%
Expected dividend yield		0.0	%		0.0	%

SUMMARY OF STOCK OPTION ACTIVITY

The following is a summary of the Company’s stock option activity for the year ended June 30, 2024 and 2023, excluding the executive Target Options:

				Weighted Average
						Remaining
				Exercise		Contractual		Intrinsic
	Options			Price		Term (Yrs)		Value
Outstanding at July 1, 2023		6,128,381		$	4.84		7.0	$	1,676,966
Options Granted		1,380,662			2.35		8.3		98,542
Options Exercised		(25,000	)		2.00		2.4		-
Options Forfeited / Cancelled		(3,840,163	)		4.81		6.5		-
Outstanding at June 30, 2024		3,643,880		$	3.95		6.5	$	-
Exercisable at June 30, 2024		1,973,499		$	4.06		5.0	$	-

				Weighted Average
						Remaining
				Exercise		Contractual		Intrinsic
	Options			Price		Term (Yrs)		Value
Outstanding at July 1, 2022		4,484,616		$	4.68		7.0	$	2,404,249
Options Granted		2,155,909			5.63		9.6		-
Options Exercised		(104,932	)		3.94		6.1		99,505
Options Forfeited / Cancelled		(407,212	)		7.39		8.5		28,830
Outstanding at June 30, 2023		6,128,381		$	4.84		7.0	$	1,676,966
Exercisable at June 30, 2023		3,741,523		$	3.96		5.6	$	1,676,966

SCHEDULE OF STOCK OPTION BASED EXPENSE

The Company’s stock option-based expense for the years ended June 30, 2024 and 2023 consisted of the following:

	For the Years Ended
	June 30,
	2024		2023
Stock option-based expense :
Research and development expenses	$	731,638	$	1,717,955
General and administrative expenses		346,309		299,664
Sales and marketing expenses		349,377		833,817
Cost of goods sold		-		755
Board option expense		179,950		441,754
Total	$	1,607,275	$	3,293,945